[Federal Register Volume 64, Number 182 (Tuesday, September 21, 1999)] [Notices] [Page 51134] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 99-24510] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel Review of the Alland R01. Date: September 23, 1999. Time: 11:00 AM to 12:30 PM. Agenda: To review and evaluate grant applications. Place: NIAID, NIH, (Room 2148), 6700-B Rockledge Drive, MSC 7610, Bethesda, MD 20892-7610, (Telephone Conference Call). Contact Person: Dianne E. Tingley, PhD, Scientific Review Administrator, Scientific Review Program, Division of Extramural Activities, NIAID, NIH, Room 2220, 6700-B Rockledge Drive, MSC 7610, Bethesda, MD 20892-7610, 301-496-2550. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: September 14, 1999. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy, NIH. [FR Doc. 99-24510 Filed 9-20-99; 8:45 am] BILLING CODE 4140-01-M